265 related articles for article (PubMed ID: 11920165)
41. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
Cheng GX; Zhu XH; Men XQ; Wang L; Huang QH; Jin XL; Xiong SM; Zhu J; Guo WM; Chen JQ; Xu SF; So E; Chan LC; Waxman S; Zelent A; Chen GQ; Dong S; Liu JX; Chen SJ
Proc Natl Acad Sci U S A; 1999 May; 96(11):6318-23. PubMed ID: 10339585
[TBL] [Abstract][Full Text] [Related]
42. The RAR alpha-PLZF chimera associated with Acute Promyelocytic Leukemia has retained a sequence-specific DNA-binding domain.
Sitterlin D; Tiollais P; Transy C
Oncogene; 1997 Mar; 14(9):1067-74. PubMed ID: 9070655
[TBL] [Abstract][Full Text] [Related]
43. Identification and characterization of PLZF as a prostatic androgen-responsive gene.
Jiang F; Wang Z
Prostate; 2004 Jun; 59(4):426-35. PubMed ID: 15065091
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-32α modulates promyelocytic leukemia zinc finger gene activity by inhibiting protein kinase Cɛ-dependent sumoylation.
Park YS; Kang JW; Lee DH; Kim MS; Bak Y; Yang Y; Lee HG; Hong J; Yoon DY
Int J Biochem Cell Biol; 2014 Oct; 55():136-43. PubMed ID: 25178676
[TBL] [Abstract][Full Text] [Related]
45. ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein.
Chevallier N; Corcoran CM; Lennon C; Hyjek E; Chadburn A; Bardwell VJ; Licht JD; Melnick A
Blood; 2004 Feb; 103(4):1454-63. PubMed ID: 14551142
[TBL] [Abstract][Full Text] [Related]
46. Histone acetyltransferase activity of p300 is required for transcriptional repression by the promyelocytic leukemia zinc finger protein.
Guidez F; Howell L; Isalan M; Cebrat M; Alani RM; Ivins S; Hormaeche I; McConnell MJ; Pierce S; Cole PA; Licht J; Zelent A
Mol Cell Biol; 2005 Jul; 25(13):5552-66. PubMed ID: 15964811
[TBL] [Abstract][Full Text] [Related]
47. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
48. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia.
Jaroslav P; Martina H; Jirí S; Hana K; Petr S; Tomás K; Julius M; Cedrik H
Leuk Lymphoma; 2005 Nov; 46(11):1605-1612. PubMed ID: 16334487
[TBL] [Abstract][Full Text] [Related]
49. Expression of selected genes and oncogenes in differentiated HL-60 cells and primary cells from human leukemias.
Shiosaka T; Tanaka Y
Anticancer Res; 1989; 9(5):1249-64. PubMed ID: 2589822
[TBL] [Abstract][Full Text] [Related]
50. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor alpha (RARalpha) and PLZF-RARalpha oncoproteins associated with acute promyelocytic leukemia.
Hong SH; David G; Wong CW; Dejean A; Privalsky ML
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9028-33. PubMed ID: 9256429
[TBL] [Abstract][Full Text] [Related]
51. Cloning and characterization of a novel zinc finger protein (MDZF) that is associated with monocytic differentiation of acute promyelocytic leukemia cells.
Yuan Z; Huang X; Zhang W; Zhang M; Wan T; Cao X
J Cancer Res Clin Oncol; 2001 Nov; 127(11):659-67. PubMed ID: 11710595
[TBL] [Abstract][Full Text] [Related]
52. Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Mikaelsson E; Danesh-Manesh AH; Lüppert A; Jeddi-Tehrani M; Rezvany MR; Sharifian RA; Safaie R; Roohi A; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Blood; 2005 Jun; 105(12):4828-35. PubMed ID: 15741214
[TBL] [Abstract][Full Text] [Related]
53. Transcriptional and post-transcriptional mechanisms induce cyclin-D1 over-expression in B-chronic lymphoproliferative disorders.
Sola B; Salaün V; Ballet JJ; Troussard X
Int J Cancer; 1999 Oct; 83(2):230-4. PubMed ID: 10471532
[TBL] [Abstract][Full Text] [Related]
54. Identification of apoptosis-related PLZF target genes.
Bernardo MV; Yelo E; Gimeno L; Campillo JA; Parrado A
Biochem Biophys Res Commun; 2007 Jul; 359(2):317-22. PubMed ID: 17537403
[TBL] [Abstract][Full Text] [Related]
55. Cyclin-dependent kinase antagonizes promyelocytic leukemia zinc-finger through phosphorylation.
Costoya JA; Hobbs RM; Pandolfi PP
Oncogene; 2008 Jun; 27(27):3789-96. PubMed ID: 18246121
[TBL] [Abstract][Full Text] [Related]
56. The Promyelocytic Leukemia Zinc Finger (PLZF ) gene is a novel transcriptional target of the CCAAT-Displacement-protein (CUX1) repressor.
Fréchette I; Darsigny M; Brochu-Gaudreau K; Jones C; Boudreau F
FEBS J; 2010 Oct; 277(20):4241-53. PubMed ID: 20945532
[TBL] [Abstract][Full Text] [Related]
57. VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression.
Han SH; Jeon JH; Ju HR; Jung U; Kim KY; Yoo HS; Lee YH; Song KS; Hwang HM; Na YS; Yang Y; Lee KN; Choi I
Oncogene; 2003 Jun; 22(26):4035-46. PubMed ID: 12821938
[TBL] [Abstract][Full Text] [Related]
58. Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia.
Hubmann R; Schwarzmeier JD; Shehata M; Hilgarth M; Duechler M; Dettke M; Berger R
Blood; 2002 May; 99(10):3742-7. PubMed ID: 11986231
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion.
Francia di Celle P; Mariani S; Riera L; Stacchini A; Reato G; Foa R
Blood; 1996 May; 87(10):4382-9. PubMed ID: 8639799
[TBL] [Abstract][Full Text] [Related]
60. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
